FIELD: medicine. SUBSTANCE: pathogenetic therapy includes the administration of myelopid in combination with antibiotics. EFFECT: shorter treatment period. 3 tbl
| Title | Year | Author | Number |
|---|---|---|---|
| METHOD OF PROGNOSTICATING PROLONGED PROGRESS OF ACUTE VIRAL HEPATITIS | 1991 |
|
RU2012881C1 |
| METHOD OF ARRESTING HEPATITE "C" CHRONISATION | 2007 |
|
RU2331436C1 |
| METHOD FOR TREATING ACUTE VIRAL HEPATITIS | 2005 |
|
RU2279280C1 |
| METHOD FOR PREDICTING INFECTIOUS TOXIC SHOCK COURSE IN LEPTOSPIROSIS PATIENTS | 2000 |
|
RU2171621C1 |
| METHOD FOR PREDICTION OF LINGERING VIRAL HEPATITIS A IN CHILDREN WITH FOOD ALLERGY | 2008 |
|
RU2382363C1 |
| METHOD FOR TREATING PATIENTS AT CHRONIC PNEUMONIA DUE TO APPLYING "RUSAM" | 2005 |
|
RU2306149C2 |
| METHOD FOR PREDICTING VIRUS HEPATITIS EXACERBATION | 2000 |
|
RU2188429C2 |
| METHOD OF TREATING MODERATELY ACTIVE AND REPLICATIVE CHRONIC VIRAL HEPATITIS TYPE C OF 1-GENOTYPE | 2009 |
|
RU2398582C1 |
| METHOD OF TREATMENT PATIENTS FOR VIRUS HEPATITIS | 0 |
|
SU1806777A1 |
| METHOD FOR TREATING THE CASES OF HEPATIC DISEASES | 2002 |
|
RU2217173C2 |
